1
|
Hornyik T, Rieder M, Castiglione A, Major P, Baczko I, Brunner M, Koren G, Odening KE. Transgenic rabbit models for cardiac disease research. Br J Pharmacol 2021; 179:938-957. [PMID: 33822374 DOI: 10.1111/bph.15484] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Revised: 02/23/2021] [Accepted: 03/11/2021] [Indexed: 12/20/2022] Open
Abstract
To study the pathophysiology of human cardiac diseases and to develop novel treatment strategies, complex interactions of cardiac cells on cellular, tissue and on level of the whole heart need to be considered. As in vitro cell-based models do not depict the complexity of the human heart, animal models are used to obtain insights that can be translated to human diseases. Mice are the most commonly used animals in cardiac research. However, differences in electrophysiological and mechanical cardiac function and a different composition of electrical and contractile proteins limit the transferability of the knowledge gained. Moreover, the small heart size and fast heart rate are major disadvantages. In contrast to rodents, electrophysiological, mechanical and structural cardiac characteristics of rabbits resemble the human heart more closely, making them particularly suitable as an animal model for cardiac disease research. In this review, various methodological approaches for the generation of transgenic rabbits for cardiac disease research, such as pronuclear microinjection, the sleeping beauty transposon system and novel genome-editing methods (ZFN and CRISPR/Cas9)will be discussed. In the second section, we will introduce the different currently available transgenic rabbit models for monogenic cardiac diseases (such as long QT syndrome, short-QT syndrome and hypertrophic cardiomyopathy) in detail, especially in regard to their utility to increase the understanding of pathophysiological disease mechanisms and novel treatment options.
Collapse
Affiliation(s)
- Tibor Hornyik
- Translational Cardiology, Department of Cardiology, Inselspital, Bern University Hospital, and Institute of Physiology, University of Bern, Bern, Switzerland.,Department of Cardiology and Angiology I, University Heart Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Marina Rieder
- Translational Cardiology, Department of Cardiology, Inselspital, Bern University Hospital, and Institute of Physiology, University of Bern, Bern, Switzerland
| | - Alessandro Castiglione
- Translational Cardiology, Department of Cardiology, Inselspital, Bern University Hospital, and Institute of Physiology, University of Bern, Bern, Switzerland
| | - Peter Major
- Institute for Genetics and Biotechnology, Hungarian University of Agriculture and Life Sciences, Gödöllő, Hungary
| | - Istvan Baczko
- Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary
| | - Michael Brunner
- Department of Cardiology and Angiology I, University Heart Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.,Department of Cardiology and Medical Intensive Care, St. Josefskrankenhaus, Freiburg, Germany
| | - Gideon Koren
- Cardiovascular Research Center, Division of Cardiology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Katja E Odening
- Translational Cardiology, Department of Cardiology, Inselspital, Bern University Hospital, and Institute of Physiology, University of Bern, Bern, Switzerland.,Department of Cardiology and Angiology I, University Heart Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| |
Collapse
|
2
|
Locati ET, Bagliani G, Cecchi F, Johny H, Lunati M, Pappone C. Arrhythmias due to Inherited and Acquired Abnormalities of Ventricular Repolarization. Card Electrophysiol Clin 2019; 11:345-362. [PMID: 31084855 DOI: 10.1016/j.ccep.2019.02.009] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Several acquired and congenital disease conditions and many cardiac and noncardiac drugs affect ventricular repolarization and increase susceptibility to ventricular arrhythmias. Abnormal ventricular repolarization can be reflected on the surface ECG by prolonged or shortened QT interval, early repolarization, and abnormal T-wave configuration. Reduced outward K+ currents and abnormal or increased sodium or calcium currents increase the vulnerability to ventricular arrhythmias. Multiple mechanisms give rise to ventricular arrhythmias in conditions of congenital or acquired abnormal ventricular repolarization. Ventricular arrhythmias associated with abnormalities of ventricular repolarization typically are rapid, usually polymorphic, ventricular tachycardia or torsades de pointes, often degenerating into ventricular fibrillation.
Collapse
Affiliation(s)
- Emanuela T Locati
- Department of Arryhmology, IRCCS San Donato Hospital, Piazza Edmondo Malan 2, 20097 San Donato Milanese, Milano, Italy; Studio Cardiologico Locati, Viale Beatrice d'Este, 20, Milano 20122, Italy.
| | - Giuseppe Bagliani
- Cardiology Department, Arrhythmology Unit, Foligno General Hospital, Via Massimo Arcamore 5, Foligno 06034, Italy; Cardiovascular Diseases Department, University of Perugia, Piazza Universita 1, Perugia 06123, Italy
| | - Franco Cecchi
- Studio Cardiologico Locati, Viale Beatrice d'Este, 20, Milano 20122, Italy; Heart and Vessels Department, University of Florence, Piazza San Marco 4, 50121 Florence, Italy; IRCCS Auxologico, Milano, Cardiovascular San Luca Hospital, Piazzale Brescia 1, 20100 Milan, Italy
| | - Helou Johny
- Cardiology Department, Arrhythmology Unit, Foligno General Hospital, Via Massimo Arcamore 5, Foligno 06034, Italy
| | - Maurizio Lunati
- Cardiothoracovascular Department, Electrophysiology Unit, Niguarda Hospital, Piazza Ospedale Maggiore 1, 20162 Milano, Italy
| | - Carlo Pappone
- Department of Arryhmology, IRCCS San Donato Hospital, Piazza Edmondo Malan 2, 20097 San Donato Milanese, Milano, Italy
| |
Collapse
|
3
|
Abstract
Cardiac delayed rectifier potassium channels conduct outward potassium currents during the plateau phase of action potentials and play pivotal roles in cardiac repolarization. These include IKs, IKr and the atrial specific IKur channels. In this article, we will review their molecular identities and biophysical properties. Mutations in the genes encoding delayed rectifiers lead to loss- or gain-of-function phenotypes, disrupt normal cardiac repolarization and result in various cardiac rhythm disorders, including congenital Long QT Syndrome, Short QT Syndrome and familial atrial fibrillation. We will also discuss the prospect of using delayed rectifier channels as therapeutic targets to manage cardiac arrhythmia.
Collapse
Affiliation(s)
- Lei Chen
- Department of Pharmacology, College of Physicians & Surgeons of Columbia University, 630 West 168th Street, New York, NY 10032, USA
| | - Kevin J Sampson
- Department of Pharmacology, College of Physicians & Surgeons of Columbia University, 630 West 168th Street, New York, NY 10032, USA
| | - Robert S Kass
- Department of Pharmacology, College of Physicians & Surgeons of Columbia University, 630 West 168th Street, New York, NY 10032, USA.
| |
Collapse
|
4
|
Romano R, Parisi V, Pastore F, Riccio A, Petraglia L, Allocca E, Leosco D. Genetic Test for the Channelopaties: Useful or Less Than Useful for Patients? (Part II). Transl Med UniSa 2013; 6:35-40. [PMID: 24251243 PMCID: PMC3829795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The advanced knowledge about genetic diseases and their mutations has widened the possibility to have a more precise and definitive diagnosis in many patients, but the use of genetic testing is still controversial. Actually, many cardiomyopathies show the availability of genetic testing. The clinical utility of this testing has been widely debated, but it is evident that the use of genetics must be put in a more organic diagnostic pathway that includes the evaluation of risks and benefits for the patient and his relatives, as well as the costs of the procedure. This review aims to clarify the role of genetic in clinics regarding Channelopaties, less frequent but equally important than other Cardiomyopathies because patients can often be asymptomatic until the first fatal manifestation.
Collapse
Affiliation(s)
- R Romano
- Department of Surgery and Cancer, Imperial College London
| | - V Parisi
- Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University of Naples “Federico II”
,
Corresponding author: Valentina Parisi (
)
| | - F Pastore
- Department of Cardiology, AOU “Maggiore Della Carità”, Novara
| | - A Riccio
- Department of Medicine, SUN, Naples
| | - L Petraglia
- Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University of Naples “Federico II”
| | - E Allocca
- Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University of Naples “Federico II”
| | - D Leosco
- Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University of Naples “Federico II”
| |
Collapse
|
5
|
Crotti L, Taravelli E, Girardengo G, Schwartz PJ. Congenital short QT syndrome. Indian Pacing Electrophysiol J 2010; 10:86-95. [PMID: 20126594 PMCID: PMC2811207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
Abstract
The Short QT Syndrome is a recently described new genetic disorder, characterized by abnormally short QT interval, paroxysmal atrial fibrillation and life threatening ventricular arrhythmias. This autosomal dominant syndrome can afflict infants, children, or young adults; often a remarkable family background of cardiac sudden death is elucidated. At electrophysiological study, short atrial and ventricular refractory periods are found, with atrial fibrillation and polymorphic ventricular tachycardia easily induced by programmed electrical stimulation. Gain of function mutations in three genes encoding K(+) channels have been identified, explaining the abbreviated repolarization seen in this condition: KCNH2 for I(kr) (SQT1), KCNQ1 for I(ks) (SQT2) and KCNJ2 for I(k1) (SQT3). The currently suggested therapeutic strategy is an ICD implantation, although many concerns exist for asymptomatic patients, especially in pediatric age. Pharmacological treatment is still under evaluation; quinidine has shown to prolong QT and reduce the inducibility of ventricular arrhythmias, but awaits additional confirmatory clinical data.
Collapse
Affiliation(s)
- Lia Crotti
- Section of Cardiology, Department of Lung, Blood and Heart, University of Pavia, Pavia, Italy ,Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy,Molecular Cardiology Laboratory, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
| | - Erika Taravelli
- Section of Cardiology, Department of Lung, Blood and Heart, University of Pavia, Pavia, Italy ,Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
| | - Giulia Girardengo
- Section of Cardiology, Department of Lung, Blood and Heart, University of Pavia, Pavia, Italy ,Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
| | - Peter J Schwartz
- Section of Cardiology, Department of Lung, Blood and Heart, University of Pavia, Pavia, Italy ,Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy,Molecular Cardiology Laboratory, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy,Laboratory of Cardiovascular Genetics, IRCCS Istituto Auxologico, Milan, Italy,Cardiovascular Genetics Laboratory, Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa,Sudden Death Chair, King Saud University, Riyadh, Saudi Arabia
| |
Collapse
|